We are live on
!
Find out more
NR
Newfound Research Portfolio holdings
AUM
$40.8M
1-Year Est. Return
12.42%
This Fund
S&P 500
This Quarter
Est. Return
+4.56%
1 Year Est. Return
-12.42%
3 Year Est. Return
+54.59%
5 Year Est. Return
+89.01%
10 Year Est. Return
–
AUM
$43.2M
AUM Growth
+$4.33M
(+11%)
Cap. Flow
+$2.88M
Cap. Flow
% of AUM
6.66%
Top 10 Holdings %
Top 10 Hldgs %
72.22%
Holding
159
New
33
Increased
13
Reduced
81
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Low Volatility Factor ETF
FDLO
|
+$1.17M |
| 2 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$1.16M |
| 3 |
Fidelity Quality Factor ETF
FQAL
|
+$1.16M |
| 4 |
JPMorgan US Quality Factor ETF
JQUA
|
+$1.16M |
| 5 |
State Street SPDR US Large Cap Low Volatility Index ETF
LGLV
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan US Momentum Factor ETF
JMOM
|
+$929K |
| 2 |
Fidelity Momentum Factor ETF
FDMO
|
+$926K |
| 3 |
iShares MSCI USA Momentum Factor ETF
MTUM
|
+$866K |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$146K |
| 5 |
Take-Two Interactive
TTWO
|
+$145K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.38% |
| 2 | Healthcare | 4.32% |
| 3 | Technology | 3.87% |
| 4 | Industrials | 2.65% |
| 5 | Consumer Staples | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Procter & Gamble
PG
$333B
| $78K | 0.18% |
575
-319
| -36% | -$41.6K |
|
52
Sherwin-Williams
SHW
$83.8B
| $78K | 0.18% |
318
+75
| +31% | +$17.9K |
|
53
Steris
STE
$22.7B
| $78K | 0.18% |
408
-279
| -41% | -$51.8K |
|
54
Visa
V
$709B
| $78K | 0.18% |
368
-199
| -35% | -$41.9K |
|
55
Yum China
YUMC
$15.3B
| $78K | 0.18% |
1,325
-841
| -39% | -$50.3K |
|
56
Edwards Lifesciences
EW
$51.8B
| $77K | 0.18% |
926
-550
| -37% | -$46.5K |
|
57
W.W. Grainger
GWW
$62.2B
| $77K | 0.18% |
193
-12
| -6% | -$4.64K |
|
58
VeriSign
VRSN
$26.6B
| $77K | 0.18% |
388
-178
| -31% | -$35K |
|
59
Clorox
CLX
$12.5B
| $76K | 0.18% |
392
+216
| +123% | +$41.6K |
|
|
EA
60
DELISTED
Electronic Arts
EA
| $76K | 0.18% |
563
-30
| -5% | -$4.16K |
|
61
HEICO Corp
HEI
$47.1B
| $76K | 0.18% |
606
-431
| -42% | -$55.4K |
|
62
Vertex Pharmaceuticals
VRTX
$139B
| $76K | 0.18% |
352
+172
| +96% | +$37.8K |
|
63
Colgate-Palmolive
CL
$72.5B
| $75K | 0.17% |
957
-536
| -36% | -$42K |
|
64
Intuitive Surgical
ISRG
$130B
| $75K | 0.17% |
306
-186
| -38% | -$46.8K |
|
65
Tyler Technologies
TYL
$15.1B
| $75K | 0.17% |
177
-28
| -14% | -$12.1K |
|
66
Zoetis
ZTS
$31B
| $75K | 0.17% |
478
-243
| -34% | -$38.5K |
|
|
ANSS
67
DELISTED
Ansys
ANSS
| $74K | 0.17% |
+218
| New | +$77.4K |
|
68
Incyte
INCY
$25.9B
| $74K | 0.17% |
905
-353
| -28% | -$30.1K |
|
|
CERN
69
DELISTED
Cerner Corp
CERN
| $74K | 0.17% |
1,028
-593
| -37% | -$44.6K |
|
70
ResMed
RMD
$34B
| $73K | 0.17% |
378
-20
| -5% | -$4.01K |
|
71
Verisk Analytics
VRSK
$24.9B
| $73K | 0.17% |
412
-199
| -33% | -$36.4K |
|
72
Regeneron Pharmaceuticals
REGN
$83.2B
| $72K | 0.17% |
+152
| New | +$74K |
|
73
Brown-Forman Class B
BF.B
$12.5B
| $71K | 0.16% |
1,035
-552
| -35% | -$40.4K |
|
74
Estee Lauder
EL
$38.4B
| $69K | 0.16% |
238
-290
| -55% | -$79.4K |
|
75
IDEX
IEX
$17.2B
| $69K | 0.16% |
328
-314
| -49% | -$62.3K |
|
Similar funds
AM
PSCM
HLC
LCM
MCMI
OMS
SEM
PIM
Newfound Research's Q1 2021 Portfolio in Review
As of Q1 2021, Newfound Research held 159 positions worth $43.2M, up 11% from $38.9M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Newfound Research deployed $2.88M of net new capital in Q1 2021, opening 33 new positions and adding to 13 existing holdings. Its largest new stake was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 69% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was JPMorgan US Momentum Factor ETF, an estimated $929K trimmed.
- Newfound Research's largest Q1 2021 buy was Fidelity Low Volatility Factor ETF: 27,216 shares worth $1.19M.
- Newfound Research added most to Vanguard US Momentum Factor ETF in Q1 2021, an estimated $984K increase.
- Newfound Research's biggest Q1 2021 reduction was JPMorgan US Momentum Factor ETF, cutting an estimated $929K.
- Newfound Research fully exited Xilinx Inc in Q1 2021, selling an estimated $146K.
- Newfound Research's ten largest holdings make up 72% of its $43.2M portfolio in Q1 2021.
- Newfound Research opened 33 new positions and closed 32 in Q1 2021.
- Newfound Research's portfolio value rose 11% quarter-over-quarter to $43.2M.
Based on Newfound Research's 13F filing for Q1 2021, filed 28 Apr 2021.